Home Cart 0 Sign in  

[ CAS No. 380380-64-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 380380-64-3
Chemical Structure| 380380-64-3
Structure of 380380-64-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 380380-64-3 ]

Related Doc. of [ 380380-64-3 ]

Alternatived Products of [ 380380-64-3 ]

Product Details of [ 380380-64-3 ]

CAS No. :380380-64-3 MDL No. :MFCD06796604
Formula : C7H6BrN5 Boiling Point : -
Linear Structure Formula :- InChI Key :JANKGNBDRWYWSN-UHFFFAOYSA-N
M.W : 240.06 Pubchem ID :23438653
Synonyms :

Calculated chemistry of [ 380380-64-3 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 11
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 50.01
TPSA : 56.49 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.74 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.96
Log Po/w (XLOGP3) : 1.44
Log Po/w (WLOGP) : 1.03
Log Po/w (MLOGP) : 0.5
Log Po/w (SILICOS-IT) : 1.15
Consensus Log Po/w : 1.22

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.8
Solubility : 0.384 mg/ml ; 0.0016 mol/l
Class : Soluble
Log S (Ali) : -2.23
Solubility : 1.41 mg/ml ; 0.00586 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.06
Solubility : 0.211 mg/ml ; 0.000879 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.31

Safety of [ 380380-64-3 ]

Signal Word:Danger Class:4.1
Precautionary Statements:P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313 UN#:1325
Hazard Statements:H315-H319-H228 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 380380-64-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 380380-64-3 ]
  • Downstream synthetic route of [ 380380-64-3 ]

[ 380380-64-3 ] Synthesis Path-Upstream   1~16

  • 1
  • [ 380380-60-9 ]
  • [ 50-00-0 ]
  • [ 380380-64-3 ]
YieldReaction ConditionsOperation in experiment
90.4% With 10% palladium on activated carbon; Degussa type; hydrogen In methanol at 20℃; for 3 h; 1.5 L of methanol,5-bromo-2- (2H-tetrazol-5-yl) pyridine (226 g)Formaldehyde (90g),10percent palladium on carbon (20 g) was added to the reactor,Under a hydrogen atmosphere (0.2 MPa)Stirred at room temperature for 3 hours, the reaction was completed,Organic phase evaporated,Recrystallization from acetonitrile,To give the product 2-methyl-5- (5-bromo-2-yl) tetrazolium,217 g, yield: 90.4percent.
Reference: [1] Patent: CN106632240, 2017, A, . Location in patent: Paragraph 0018-0019
  • 2
  • [ 97483-77-7 ]
  • [ 77-78-1 ]
  • [ 380380-64-3 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With sodium azide; ammonium chloride In dimethyl sulfoxide at 95℃; for 4 h;
Stage #2: at 50℃; for 24 h;
Stage #3: for 3 h;
The 5 - bromo -2 - cyano pyridine (800g, 4.4 µM), dimethyl sulfoxide (4L) adding 20L in the bottle, addition of sodium azide (425.7g, 6 . 55 µM), ammonium chloride (350.3g, 6 . 55 µM), stirring, heated to 95 degrees, stirring 4 hours, cooling to room temperature.By adding sodium hydroxide (470g, 11.8 µM), dropping the dimethyl sulfate (665g, 5.3 µM), heating up to 50 degrees, stirring 24 hours, the reaction is finished, the addition of water (11L), centrifugal drying to obtain the crude product.The crude product by adding dilute hydrochloric acid, stirring 3 hours, filtration, the aqueous phase is 40percent of NaOH to adjust the PH=9 - 10, separating out 2 - methyl -5 - (5 - bromo pyridine -2 - yl) tetrazole, (792g, 3.3 µM), yield: 75percent.
Reference: [1] Patent: CN106699730, 2017, A, . Location in patent: Paragraph 0016; 0017; 0018; 0019; 0020; 0021
  • 3
  • [ 97483-77-7 ]
  • [ 380380-64-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 22, p. 5909 - 5915
[2] Patent: CN106432182, 2017, A,
[3] Patent: CN106432182, 2017, A,
[4] Patent: CN106432182, 2017, A,
[5] Patent: CN106432182, 2017, A,
[6] Patent: CN106432182, 2017, A,
[7] Patent: WO2008/108988, 2008, A1,
[8] Patent: WO2005/116023, 2005, A1, . Location in patent: Page/Page column 67
  • 4
  • [ 380380-60-9 ]
  • [ 74-88-4 ]
  • [ 380380-64-3 ]
YieldReaction ConditionsOperation in experiment
70.5% With calcium hydroxide In dichloromethane; N,N-dimethyl-formamide at 0 - 40℃; for 24 h; The 5-bromo-2-(2H-tetrazol-5-yl)pyridine (20.0 g, 88.4 mmol) prepared in Example 1 was added with 20.0 mL of N,N-dimethyl formamide and 180.0 mL of methylene chloride and then further added with calcium hydroxide (3.94 g, 53.0 mmol), after which iodomethane (33.0 mL, 530.4 mmol) was slowly added dropwise thereto at 0°C. Thereafter, the reaction solution was warmed to 40°C and stuffed for 24 hr. After the termination of the reaction, the reaction solution was added with water, thus extracting an organic layer. The extracted organic layer was washed with saline and further extracted. The resulting organic layer was added with 300.0 mL of a 6 N hydrochloric acid aqueous solution to thus extract an aqueous layer, after which the separated organic layer was added with 60.0 mL of a 6 N hydrochloric acid aqueous solution, so that the aqueous layer was further extracted. Extraction was performed using HPLC until the amount of Ni was less than 5percent. The separated aqueous layer was collected, and the pH thereof was adjusted to 10.6 at 40°C or less using a 50percent sodium hydroxide aqueous solution. The produced solid was filtered, washed with water, and concentrated under reduced pressure, thus obtaining a desired compound. Yield (16.2 g, 70.5percent), N2/N] ratio percent (98/2)
Reference: [1] Patent: WO2017/99530, 2017, A1, . Location in patent: Paragraph 51; 52; 53; 54; 55; 56; 57
  • 5
  • [ 380380-60-9 ]
  • [ 74-88-4 ]
  • [ 380380-64-3 ]
  • [ 380380-63-2 ]
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1305 - 1313
[2] Patent: WO2004/48350, 2004, A2, . Location in patent: Page 60-61
[3] Patent: WO2004/56819, 2004, A1, . Location in patent: Page 52-53
[4] Patent: WO2004/56818, 2004, A1, . Location in patent: Page 52-53
[5] Patent: WO2004/56816, 2004, A1, . Location in patent: Page 52-53
[6] Patent: WO2008/108988, 2008, A1, . Location in patent: Page/Page column 52
  • 6
  • [ 1374651-37-2 ]
  • [ 380380-64-3 ]
YieldReaction ConditionsOperation in experiment
33% With sodium hydroxide; methyl iodide In tetrahydrofuran; N,N-dimethyl-formamide at 48℃; Cooling with ice/brine To a 22-L, four-neck, round-bottom flask equipped with an overhead stirrer, nitrogen inlet/outlet, and thermocouple placed in an ice/brine bath was charged the tetrazole ammonium salt (835.0 g, 3.44 mol, 1 weight), tetrahydrofuran (7.5 L, 9 volumes), ΛζjV-dimethylformamide (2.5 L, 3 volumes) and sodium hydroxide powder (343.5 g, 8.59 mol, 2.5 equivalents) while stirring. The internal reactor temperature was allowed to reach 12°C, whereupon iodomethane (1.22 kg, 8.59 mol, 2.5 equivalents) was added dropwise over 50 minutes, maintaining the reaction temperature below 200C. After 20 minutes addition time, due to a rapid increase in temperature, the addition was paused and the reaction continued to self-heat from 15-200C over ten minutes. The remainder of the addition was completed at constant temperature (18°C ). Upon completion of the addition, the ice/brine bath was removed and the reactor was equipped with a water condenser and a heating mantle. The internal reactor temperature was adjusted to 400C, however the reaction continued to self- heat to 48°C. The reaction was judged to be complete after 6 hours by HPLC analysis by complete consumption of the starting material. The reaction mixture was cooled to room temperature overnight for convenience. The THF was removed by distillation, and water (8.35 L, 10 volumes) was charged to the reactor. The slurry was stirred for 30 minutes and filtered by vacuum filtration and the reactor and filter cake were washed with water (4.2 L, 5 volumes) to afford crude 4/Nl isomer mixture as a peach colored solid (500.7 g, 61percent yield, 3.85: 1 4: Nl).[0047] The solids (500.7 g) were dissolved in CH2Cl2 (2.5 L, 5 volumes) to which 6 N aqueous HCl (7.5 L, 15 volumes) was added. The biphasic mixture was stirred and the layers were separated. At this point, the desired product is in the aqueous HCl layer. The CH2Cl2 layer was washed with 6 N aqueous HCl (4.5 L, 3 x 3 volumes) until <5percent AUC 4 was present by HPLC analysis. The combined 6 N HCl extracts were transferred to a reactor and the pH was adjusted to 10.6 with 50percent aqueous NaOH (-3.2 L) while maintaining the internal temperature below 400C. The solids were isolated by vacuum filtration and the reactor and filter cake were rinsed with water (1 L, 2 volumes) to afford crude 4 as a yellow/orange solid (322.4 g, 64percent recovery, 39percent yield, 93.5percent AUC 4, 4.1percent AUC N-I isomer) as confirmed by HPLC and 1H NMR analyses.[0048] The crude 4 was further purified by an isopropyl acetate (IPAc) reslurry (1.61 L, 5 volumes) at 500C for 1 hour. Upon cooling to room temperature, the solids were filtered and the reactor and filter cake were washed with additional IPAc (500 mL, 1.6 volumes) to afford purified 4 as a off-white/yellow solid (275.5 g, 85percent recovery, 33percent yield, 98.2percent AUC) as confirmed by HPLC and 1H NMR analyses. DSC analysis of 4 showed a decomposition exotherm at approximately 245°C. Example 3: Preparation of benzyl (4-bromo-3-fluorophenyl)carbamate, 5 [0049] To a 12-L, three-neck, round-bottom flask equipped with an overhead stirrer, nitrogen inlet/outlet, addition funnel and thermocouple was charged 4-bromo-3- fluoroaniline (800.0 g, 4.21 mol, Matrix lot No. Q13H), THF (6.4 L, 8 vol), and solid sodium bicarbonate (530.5 g, 6.32 mol, 1.5 eq). The addition funnel was charged with benzyl chloroformate (861.9 g, 5.05 mol, 1.2 eq), which was added dropwise to the reactor over 70 minutes. The temperature of the reaction was maintained below 200C with an ice water bath. The batch was aged 1 hour at room temperature at which point HPLC analysis indicated that the reaction was complete. The reaction mixture was transferred to a 22-L flask and the mixture was diluted with water (6.4 L, 8 vol). The two-phase mixture was warmed to 50°C and held at temperature for 16 hours to quench the excess benzyl chloroformate. The mixture was transferred hot to a separatory funnel to remove the lower aqueous phase. A rag layer was observed which was taken with the aqueous layer. The THF layer was filtered through Whatman No.1 filter paper to remove some particulates, and the mixture was transferred back to a 22-L flask equipped for distillation. Heptane was added in portions and distilled to remove the THF. (Note that it is best to distill some of the THF out first before adding the first amount of heptane.) A total of 26.5 L of heptane was added, and the total distillate collected was 25 L. At this point, the pot temperature had reached 97.7°C and the distillate coming over contained 0.9percent THF by 1H NMR analysis. The mixture was cooled to room temperature and the thick white slurry was filtered. The filter cake was washed with heptane (4 L). The product was dried in a vacuum oven at 400C to give 1257.0 g of intermediate 5 (92percent yield). The HPLC assay was 98.3percent (AUC).
Reference: [1] Patent: WO2010/42887, 2010, A2, . Location in patent: Page/Page column 15-16
  • 7
  • [ 74-88-4 ]
  • [ 380380-60-9 ]
  • [ 380380-64-3 ]
  • [ 380380-63-2 ]
YieldReaction ConditionsOperation in experiment
45% With sodium hydroxide In N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere To a solution of 2-(tetrazol-5-yl)-5-bromopyridine 8 (10.5 g, 46.5 mmol) in DMF (100 mL) at 0 °C was slowly added NaOH (6.50 g, 162 mmol) and iodomethane (4.08 mL, 65.5 mmol). After being stirred at room temperature for 6 h, the reaction mixture was poured into water and extracted with EtOAc. The organic layer was washed with brine, dried over anhydrous MgSO4, filtered and concentrated in vacuo. The crude product was purified by column chromatography to obtain the title compound (5 g, 45percent). 1H NMR (CDCl3): δ 8.80 (d, J = 2.0 Hz, 1H), 8.13 (d, J = 8.4 Hz, 1H), 7.98 (dd, J = 8.4 Hz, 2.4 Hz, 1H), 4.42 (s, 3H).
4 g With sodium hydroxide In N,N-dimethyl-formamide at 0 - 20℃; for 6 h; Will be 10.5 grams2- (tetrazol-5-yl) -5-bromopyridine was dissolved100 ml of dimethylformamide,Then 6.5 g of sodium hydroxide was added to the solution,And 9.3 g of methyl iodide was slowly added to the solution at 0 ° C. The solution was stirred at room temperature for 6 hours,Water was then added and extracted with ethyl acetate.The resulting organic layer was washed with brine, dehydrated, filtered, concentrated in vacuo and purified by column chromatography to give 4 g of 2- (1-methyltetrazol-5-yl) -5-bromopyridine and 5 g of 2- (2 -methyltetrazol-5-yl) -5-bromopyridine.
Reference: [1] European Journal of Medicinal Chemistry, 2011, vol. 46, # 4, p. 1027 - 1039
[2] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 22, p. 5909 - 5915
[3] Patent: WO2005/58886, 2005, A1, . Location in patent: Page/Page column 26; 27
[4] Patent: WO2006/38100, 2006, A1, . Location in patent: Page/Page column 67-68
[5] Patent: CN106146559, 2016, A, . Location in patent: Paragraph 0050
[6] Patent: US2003/166620, 2003, A1,
[7] Patent: WO2005/116022, 2005, A1, . Location in patent: Page/Page column 50
[8] Patent: WO2005/116023, 2005, A1, . Location in patent: Page/Page column 67-68
  • 8
  • [ 18107-18-1 ]
  • [ 380380-60-9 ]
  • [ 380380-64-3 ]
  • [ 380380-63-2 ]
Reference: [1] Patent: US2004/33970, 2004, A1, . Location in patent: Page/Page column 9
  • 9
  • [ 97483-77-7 ]
  • [ 380380-64-3 ]
  • [ 380380-63-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2011, vol. 46, # 4, p. 1027 - 1039
[2] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1305 - 1313
[3] Patent: CN106146559, 2016, A,
[4] Patent: WO2005/116022, 2005, A1,
  • 10
  • [ 624-28-2 ]
  • [ 380380-64-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2004, vol. 12, # 22, p. 5909 - 5915
  • 11
  • [ 624-28-2 ]
  • [ 380380-64-3 ]
  • [ 380380-63-2 ]
Reference: [1] European Journal of Medicinal Chemistry, 2011, vol. 46, # 4, p. 1027 - 1039
[2] Patent: CN106146559, 2016, A,
  • 12
  • [ 380380-64-3 ]
  • [ 856866-72-3 ]
YieldReaction ConditionsOperation in experiment
48% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; lithium chloride In N,N-dimethyl-formamide at 90℃; for 4 h; In a 100 ml reaction flask,Compound 7 (5.0 g, 10 mmol) and 50 ml of DMF were added,2- (1-methyl-tetrazol-5-yl) -5-bromopyridine (2.65, 11 mmol)Lithium chloride (1.7 g),1,1'-bis (diphenylphosphino) ferrocene] palladium chloride (1.0 g),The mixture was stirred at 90 ° C for 4 hours,After completion of the reaction,To room temperature,And extracted three times with water / ethyl acetate (V / V = 1: 1)The organic layers were combined,Dried over anhydrous sodium sulfate,And concentrated to give 1.7 g of the compound (1)The yield was 48percent
26% With lithium chloride In 1-methyl-pyrrolidin-2-one at 20 - 120℃; for 4 h; In 150ml of 1-methyl-2-pyrrolidone was dissolved 37g of (R)-3- (4- tributhylstannyl-3-fluorophenyl)-2-oxo-5-oxazolidinylmethanol. The solution was added with 19.7g of 2- (2-methyltetrazol-5-yl)-5-bromopyridine, 10.44g of lithium chloride and 2.9g of dichlorobistriphenylphospine palladium (I I) at room temperature and then stirred at the temperature of 120 C for 4 hours. The reaction mixture was added with water and then extracted with ethyl acetate. The organic layer, thus separated, was washed with brine, dehydrated, filtrated, concentrated in vacuo and purified by column chromatography to provide 8g of the title compound. Yield 26percent. 1H NMR (DMSO-d6) 5 8.90 (s, lH), 8. 18 (m, 2H), 7.70 (m, 2H), 7.49 (dd, 1H), 5.25 (t, 1H), 4.74 (m, 1H), 4.46 (s, 3H), 4.14 (t, lH), 3. 88 (dd, lH), 3.68 (m, lH), 3. 58 (m, lH)
26% With bis-triphenylphosphine-palladium(II) chloride; lithium chloride In 1-methyl-pyrrolidin-2-one at 120℃; for 4 h; Inert atmosphere To a solution of (R)-3-(4-tributhylstannyl-3-fluorophenyl)-2-oxo-5-oxazolidinylmethanol 5 (37.0 g, 74.0 mmol) in NMP (150 mL) was added 2-(2-methyltetrazol-5-yl)-5-bromopyridine 9 (19.7 g, 81.9 mmol), LiCl (10.4 g, 245 mmol) and Pd(PPh3)2Cl2 (2.90 g, 4.13 mmol). The reaction mixture was stirred for 4 h at 120 °C. After being cooled to room temperature, the reaction mixture was poured into water and extracted with EtOAc. The organic layer was washed with brine, dried over anhydrous MgSO4, filtered and concentrated in vacuo. The residue was further purified by column chromatography to obtain the title compound (8 g, 26percent). Mp: 201 °C. 1H NMR (DMSO-d6): δ 8.90 (s, 1H), 8.18 (m, 2H), 7.70 (m, 2H), 7.49 (dd, J = 8.8 Hz, 2.4 Hz, 1H), 5.25 (t, J = 5.6 Hz, 1H), 4.74 (m, 1H), 4.46 (s, 3H), 4.14 (t, J = 8.8 Hz, 1H), 3.88 (m, 1H), 3.68 (m, 1H), 3.58 (m, 1H). 13C NMR (DMSO-d6): δ 163.56, 159.03, 154.06, 149.18, 144.78, 140.30, 136.96, 131.42, 130.73, 121.89, 118.36, 113.81, 105.18, 73.39, 61.52, 45.96, 39.63. IR (neat, cm-1): 3251.40, 1746.23, 1619.91, 1473.35, 1406.82. [M + H]+: 371.02. HRMS [EI-MS]: m/z, calculated for [C17H15FN6O3] 370.1190, found, 370.1100 [C17H15FN6O3].
Reference: [1] Patent: CN105859780, 2016, A, . Location in patent: Paragraph 0038
[2] Patent: WO2005/58886, 2005, A1, . Location in patent: Page/Page column 28; 29
[3] European Journal of Medicinal Chemistry, 2011, vol. 46, # 4, p. 1027 - 1039
[4] Patent: CN107400126, 2017, A, . Location in patent: Paragraph 0036
  • 13
  • [ 444335-16-4 ]
  • [ 380380-64-3 ]
  • [ 856866-72-3 ]
YieldReaction ConditionsOperation in experiment
83%
Stage #1: With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; potassium acetate; bis(pinacol)diborane In dimethyl sulfoxide at 80℃; for 14 h; Inert atmosphere
Stage #2: With dichloro(1,1'-bis(diphenylphosphanyl)ferrocene)palladium(II)*CH2Cl2; caesium carbonate In 1,4-dioxane; water at 70℃; for 3 h; Inert atmosphere
DMSO (100 ml) was added to a 250 ml reaction flask,(5R) -3- (4-bromo-3-fluorophenyl) -5-hydroxymethyloxazolidin-2-one(10 g, 34.5 mmol), pinacolate (17.52 g, 69 mmol),[1,1'-bis (diphenylphosphino) ferrocene] dichloropalladium dichloromethane complex (1.41 g, 1.73 mmol)And potassium acetate (13.5 g, 138 mmol), and the temperature was raised to 80 ° C under a nitrogen atmosphere,For 14 hours. The heating was stopped, the solution was cooled to room temperature, and extracted with water / ethyl acetate 3 times. The organic layers were combined and the organic layer was washed with saturated waterBrine, dried over anhydrous sodium sulfate and concentrated by suction filtration. The concentrated product of the above step was added to a 250 ml reaction flask,1,4-dioxane (100 ml) was added,5-bromo-2- (2-methyl-2H-tetrazol-5-yl) pyridine(8.28 g, 34.5 mmol),[1,1'-bis (diphenylphosphino) ferrocene] dichloropalladium dichloromethane complex (0.56 g, 0.69 mmol)And cesium carbonate aqueous solution (50 ml, containing 33.72 g of cesium carbonate, 103.5 mmol),Under nitrogen protection,The temperature was raised to 70 ° C,The reaction was carried out for 3 hours,Dichloromethane was added for extraction.The separated organic phase was washed with saturated brine,Anhydrous sodium sulfate dehydration,filter,Concentrated in vacuo and purified by column chromatography,10.6 g of a solid was obtained,The yield was 83.0percentHPLC purity was 98.34percent (area normalization method).
Reference: [1] Patent: CN105418678, 2016, A, . Location in patent: Paragraph 0070; 0071; 0072; 0073; 0074; 0075
  • 14
  • [ 380380-64-3 ]
  • [ 856866-72-3 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 2, p. 143 - 146
  • 15
  • [ 73183-34-3 ]
  • [ 380380-64-3 ]
  • [ 1056039-83-8 ]
YieldReaction ConditionsOperation in experiment
86.3% With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In 1,4-dioxane at 80℃; for 3 h; Sealed tube; Inert atmosphere To a solution of 10 (1.00 g, 4.17 mmol) in dry degassed l,4-dioxane (15 mL) was added bis(pinacolato)diboron (1.27 g, 5.00 mmol), potassium acetate (1.35 g, 13.75 mmol), and Pd(dppf)Cl2 (0.26 g, 0.35 mmol). The reaction mixture was heated at 80 °C for 3 h in a sealed tube under argon. The reaction mixture was filtered through silica gel flash column with CH2Cl2 and the organic layer was evaporated under reduced pressure, and the residue was washed with n-hexane to obtain the title compound (1.03 g, 86.3 percent). 1H-NMR (400 MHz, CDCl3) δ: 9.14 (s, 1H), 8.30 (m, 2H), 4.48 (s, 3H), 1.38 (s, 12H).
66% With potassium acetate In dimethyl sulfoxide at 80℃; for 2 h; To the solution of 5-bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine (480 mg, 2 mmol) in DMSO (5 mL) was added pinacol diborane (1.02 g, 4 mmol), KOAc (588 mg, 6 mmol) and PdCl2(dppf)DCM (160 mg, 0.2 mmol), degassed with N2. The mixture was stirred at 80 0C for 2 h. The reaction mixture was diluted with DCM (100 mL) and washed with brine (2 x 100 mL), dried (Na2SO4) and evaporated under vacuum, then purified by prep-TLC (hexanes - EtOAc) to give 2-(2-methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl- l,3,2-dioxaborolan-2-yl)pyridine as white solid (380 mg, 66percent yield).
Reference: [1] Chemical and Pharmaceutical Bulletin, 2015, vol. 63, # 2, p. 143 - 146
[2] Patent: WO2008/108988, 2008, A1, . Location in patent: Page/Page column 53
[3] European Journal of Organic Chemistry, 2016, vol. 2016, # 7, p. 1305 - 1313
[4] Patent: WO2009/74812, 2009, A1, . Location in patent: Page/Page column 41
[5] Patent: US2010/69441, 2010, A1, . Location in patent: Page/Page column 21-22
[6] Patent: US2010/204477, 2010, A1, . Location in patent: Page/Page column 31
[7] Patent: CN105367547, 2016, A, . Location in patent: Paragraph 0034; 0035; 0036
[8] Patent: CN107382995, 2017, A, . Location in patent: Paragraph 0007; 0014; 0015; 0016; 0117; 0018; 0019-0022
  • 16
  • [ 874290-59-2 ]
  • [ 380380-64-3 ]
  • [ 1220910-89-3 ]
YieldReaction ConditionsOperation in experiment
87% With potassium carbonate In 1,4-dioxane; water at 70℃; for 1 h; Inert atmosphere To a 5 -L, three-neck, round-bottom flask was charged 4 (200.0 g, 0.833 mol) followed by 1,4-dioxane (3 L, 15 vol). Crude compound 6 (361.2 g, 1.249 mol, 1.5 equiv.), Pd2(dba)3 (11.44 g, 0.0125 g, 0.015 equiv.), and PCy3 (7.0 g, 0.025 mol, 0.03 equiv.) was charged and degassed with nitrogen for 30 minutes. A solution Of K2CO3 (195.7 g, 1.7 equiv.) in water (800 mL, 4 vol) was charged, and the reaction was heated to 70 0C. The reaction was complete after 1 hour with 0.5 area percent of 4 remaining. The reaction was cooled to 50 0C, and Darco G-60 (40 g, 0.2 wt) was added and stirred for 30 minutes. Celite 545 (40 g, 0.2 wt) was charged and then the reaction was filtered through Celite 545 (100 g, 0.5 wt) wetted with water (300 mL). The hot filtration into the water from the Celite caused precipitation of the product. Tetrahydrofuran (1.2 L, 6 vol) and brine (600 mL, 3 vol) were added, and the product re-dissolved at room temperature. The phase split was accomplished cleanly (Vmax = 28 volumes). The dioxane was concentrated and ethanol (1 L, 5 vol) was added and concentrated. Then the product was reslurried in ethanol: water (4: 1, 2 L, 10 vol) at 700C, cooled to room temperature over 3 hours, filtered and washed with ethanol (2 x 400 mL). Compound 7 was isolated in 87percent yield (292.6 g) with a purity of 97.7 percent (AUC) by HPLC analysis. The 1H NMR and 19F NMR indicated the presence of one compound. Pd analysis showed 135 ppm Pd was in the product.
Reference: [1] Patent: WO2010/42887, 2010, A2, . Location in patent: Page/Page column 18-19
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 380380-64-3 ]

Tedizolid Related Intermediates

Chemical Structure| 624-28-2

[ 624-28-2 ]

2,5-Dibromopyridine

Chemical Structure| 656-65-5

[ 656-65-5 ]

4-Bromo-3-fluoroaniline

Chemical Structure| 113826-06-5

[ 113826-06-5 ]

(2R)-(-)-Glycidyl tosylate

Chemical Structure| 97483-77-7

[ 97483-77-7 ]

5-Bromopicolinonitrile

Chemical Structure| 510729-01-8

[ 510729-01-8 ]

Benzyl (4-bromo-3-fluorophenyl)carbamate

Related Functional Groups of
[ 380380-64-3 ]

Bromides

Chemical Structure| 1211516-09-4

[ 1211516-09-4 ]

6-Bromo-1H-pyrazolo[4,3-b]pyridin-3-amine

Similarity: 0.66

Chemical Structure| 1150617-54-1

[ 1150617-54-1 ]

6-Bromo-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.60

Chemical Structure| 1150617-56-3

[ 1150617-56-3 ]

6-Bromo-1-methyl-1H-pyrazolo[4,3-b]pyridine

Similarity: 0.56

Chemical Structure| 1251953-03-3

[ 1251953-03-3 ]

(5-Bromopyridin-2-yl)methanamine dihydrochloride

Similarity: 0.56

Chemical Structure| 173999-23-0

[ 173999-23-0 ]

(5-Bromopyridin-2-yl)methanamine

Similarity: 0.55

Related Parent Nucleus of
[ 380380-64-3 ]

Pyridines

Chemical Structure| 1056039-83-8

[ 1056039-83-8 ]

2-(2-Methyl-2H-tetrazol-5-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Similarity: 0.65

Chemical Structure| 3250-74-6

[ 3250-74-6 ]

3-(2H-Tetrazol-5-yl)pyridine

Similarity: 0.57

Chemical Structure| 1251953-03-3

[ 1251953-03-3 ]

(5-Bromopyridin-2-yl)methanamine dihydrochloride

Similarity: 0.56

Chemical Structure| 51285-26-8

[ 51285-26-8 ]

Picolinimidamide hydrochloride

Similarity: 0.55

Chemical Structure| 173999-23-0

[ 173999-23-0 ]

(5-Bromopyridin-2-yl)methanamine

Similarity: 0.55